856 related articles for article (PubMed ID: 26410359)
1. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS).
Hessam S; Sand M; Gambichler T; Bechara FG
J Am Acad Dermatol; 2015 Dec; 73(6):998-1005. PubMed ID: 26410359
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the Use of Hematological Parameters in Staging Hidradenitis Suppurativa.
Yaşar NF; Uylas MU; Baspinar M; Sarsilmaz H; Ates E; Erkasap S; Sahin A
Wounds; 2016 Nov; 28(11):87-91. PubMed ID: 28054922
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte Profile in Peripheral Blood and Neutrophil-Lymphocyte Ratio in Hidradenitis Suppurativa: A Comparative Cross-Sectional Study of 462 Cases.
Miller IM; Ring HC; Prens EP; Rytgaard H; Mogensen UB; Ellervik C; Jemec GB
Dermatology; 2016; 232(4):511-9. PubMed ID: 27287331
[TBL] [Abstract][Full Text] [Related]
4. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
5. Serum amyloid A and C-reactive protein levels and erythrocyte sedimentation rate are important indicators in hidradenitis suppurativa.
Akdogan N; Dogan S; Incel-Uysal P; Karabulut E; Topcuoglu C; Yalcin B; Atakan N
Arch Dermatol Res; 2020 May; 312(4):255-262. PubMed ID: 31729595
[TBL] [Abstract][Full Text] [Related]
6. Combination of oral zinc gluconate and topical triclosan: An anti-inflammatory treatment modality for initial hidradenitis suppurativa.
Hessam S; Sand M; Meier NM; Gambichler T; Scholl L; Bechara FG
J Dermatol Sci; 2016 Nov; 84(2):197-202. PubMed ID: 27554338
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa.
Jiménez-Gallo D; de la Varga-Martínez R; Ossorio-García L; Albarrán-Planelles C; Rodríguez C; Linares-Barrios M
Mediators Inflamm; 2017; 2017():2450401. PubMed ID: 28769536
[TBL] [Abstract][Full Text] [Related]
8. A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa.
Hessam S; Scholl L; Sand M; Schmitz L; Reitenbach S; Bechara FG
JAMA Dermatol; 2018 Mar; 154(3):330-335. PubMed ID: 29417136
[TBL] [Abstract][Full Text] [Related]
9. Patients with hidradenitis suppurativa carry a higher systemic inflammatory load than other dermatological patients.
Riis PT; Søeby K; Saunte DM; Jemec GB
Arch Dermatol Res; 2015 Dec; 307(10):885-9. PubMed ID: 26350517
[TBL] [Abstract][Full Text] [Related]
10. Effects of adalimumab on T-helper-17 lymphocyte- and neutrophil-related inflammatory serum markers in patients with moderate-to-severe hidradenitis suppurativa.
Jiménez-Gallo D; de la Varga-Martínez R; Ossorio-García L; Collantes-Rodríguez C; Rodríguez C; Linares-Barrios M
Cytokine; 2018 Mar; 103():20-24. PubMed ID: 29289722
[TBL] [Abstract][Full Text] [Related]
11. Visfatin and insulin levels and cigarette smoking are independent risk factors for hidradenitis suppurativa: a case-control study.
Akdogan N; Alli N; Uysal PI; Topcuoglu C; Candar T; Turhan T
Arch Dermatol Res; 2018 Dec; 310(10):785-793. PubMed ID: 30293125
[TBL] [Abstract][Full Text] [Related]
12. Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity.
Schrader AM; Deckers IE; van der Zee HH; Boer J; Prens EP
J Am Acad Dermatol; 2014 Sep; 71(3):460-7. PubMed ID: 24880664
[TBL] [Abstract][Full Text] [Related]
13. Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement.
Deckers IE; van der Zee HH; Boer J; Prens EP
J Am Acad Dermatol; 2015 Mar; 72(3):485-8. PubMed ID: 25582541
[TBL] [Abstract][Full Text] [Related]
14. Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study.
Vossen ARJV; Schoenmakers A; van Straalen KR; Prens EP; van der Zee HH
Am J Clin Dermatol; 2017 Oct; 18(5):687-695. PubMed ID: 28429245
[TBL] [Abstract][Full Text] [Related]
15. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the laboratory parameters in hidradenitis suppurativa: Can we use new inflammatory biomarkers?
Çetinarslan T; Türel Ermertcan A; Özyurt B; Gündüz K
Dermatol Ther; 2021 Mar; 34(2):e14835. PubMed ID: 33527638
[TBL] [Abstract][Full Text] [Related]
17. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.
Fang L; Wei H; Mak KH; Xiong Z; Song J; Wang D; Lim YL; Chatterjee S
Can J Cardiol; 2004 Dec; 20(14):1433-8. PubMed ID: 15614337
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin Levels and Serum C-Reactive Protein in Patients With Moderate to Severe Hidradenitis Suppurativa.
Huang CM; Lowes MA; Cserti C; Alavi A
J Cutan Med Surg; 2019; 23(5):501-506. PubMed ID: 31253065
[TBL] [Abstract][Full Text] [Related]
19. Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa.
Saraç Öztürk G; Ergun T; Peker Eyüboğlu İ; Akkiprik M
Cytokine; 2021 Aug; 144():155585. PubMed ID: 34034145
[TBL] [Abstract][Full Text] [Related]
20. Haptoglobin is an independent marker for disease severity and risk for metabolic complications in hidradenitis suppurativa: A prospective study.
Abu Rached N; Gambichler T; Ocker L; Skrygan M; Seifert C; Scheel CH; Stockfleth E; Bechara FG
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):205-213. PubMed ID: 37669834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
